Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin
- 16 October 2001
- journal article
- clinical trial
- Published by Elsevier in Epilepsy Research
- Vol. 47 (1-2) , 55-63
- https://doi.org/10.1016/s0920-1211(01)00293-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Antiepileptic Drug Pharmacokinetics and Interactions: Impact on Treatment of EpilepsyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
- Pharmacokinetic profile of levetiracetamPharmacology & Therapeutics, 2000
- Allelic, genotypic and phenotypic distributions of S-mephenytoin 4???-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the worldPharmacogenetics, 1999
- Drug interactions in human neuropathic pain pharmacotherapyPain, 1997
- A Review of Enzyme Induction of Warfarin Metabolism with Recommendations for Patient ManagementPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1997
- Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patientsChirality, 1997
- Clinically Important Drug Interactions with AnticoagulantsClinical Pharmacokinetics, 1996
- Adverse Interactions Between Warfarin and Nonsteroidal Antiinflammatory Drugs: Mechanisms, Clinical Significance, and AvoidanceAnnals of Pharmacotherapy, 1995
- Antiepileptic DrugsDrug Safety, 1993
- Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactionsChemical Research in Toxicology, 1992